Structuring negotiations between insurers and providers, standardizing fee-for-service payments and negotiating prices can lower the United States' health care spending by slowing the rate at which healthcare prices increase, ...
Nov 22, 2020
10
171
More than 1.1 million Medicare patients could die over the next decade because they cannot afford to pay for their prescription medications, according to a new study released today by the West Health Policy Center, a nonprofit ...
Nov 19, 2020
0
3
When governments create a minimum price for alcoholic beverages, deaths and hospitalizations related to alcohol use significantly decrease, according to results from a new report in the Journal of Studies on Alcohol and Drugs.
Oct 16, 2020
0
0
Insulin prices are more than eight times higher in the United States than in 32 high-income comparison nations combined, according to a new RAND Corporation study.
Oct 6, 2020
0
2
The World Health Organization announced Monday that it and leading partners have agreed to a plan to roll out 120 million rapid-diagnostic tests for the coronavirus to help lower- and middle-income countries make up ground ...
Sep 28, 2020
0
2
Using a device that could be built with a dollar's worth of open-source parts and a 3-D-printed case, researchers want to help the hundreds of millions of older people worldwide who can't afford existing hearing aids to address ...
Sep 23, 2020
1
132
Prices paid to hospitals nationally during 2018 by privately insured patients averaged 247% of what Medicare would have paid, with wide variation in prices among states, according to a new RAND Corporation study.
Sep 18, 2020
0
5
The race is on to develop a COVID-19 vaccine, but even when one becomes available a large challenge will still exist: getting enough people vaccinated.
Sep 11, 2020
0
5
The NHS would spend billions of pounds more on drugs if it had to pay US prices following a US/UK trade deal. According to a new study by researchers at Brigham and Women's Hospital in Boston, Harvard Medical School, and ...
Sep 11, 2020
0
3
Conventional drug costing models are unlikely to apply when it comes to putting a price tag on a vaccine against COVID-19 for Canadians, according to health economist Christopher McCabe of the University of Alberta's Faculty ...
Sep 3, 2020
0
2
